Tuesday, February 3 at 11:55 am

Speakers:

• Ashley Davidson, Vice President, Product Lead, Advarra

Access to site performance data is transforming how we evaluate and qualify clinical trial sites. By integrating these insights with feasibility workflows, sponsors and CROs can achieve a more holistic, data-driven approach that reduces site burden, accelerates decision-making, and redefines site feasibility for the future.

• Ian Bailey, Managing Director, AI & Data Science Analytics, Advarra
• Jamie Bendrick-Peart, Senior Director, Innovation and Strategic Projects, AstraZeneca
  
  

What if we could validate study assumptions before the first site is activated? This discussion dives into how combining AI with operational datasets enables sponsors to evaluate design hypotheses, identify amendment risks early, and optimize trial execution. Hear from industry leaders on how data-driven insights are reshaping protocol development and improving decision-making across the clinical lifecycle.

Tuesday, February 3 at 3:30 pm

Panel Moderator: Christine Senn, Senior Vice President, Site-Sponsor Innovation, Advarra

• Jennifer Byrne, CEO, Javara, Inc.
• Patrick A. Floody, Vice President, Global Clinical Trial Services, Regeneron Pharmaceuticals, Inc.
• Alison Liddy, Senior Vice President, Patient and Site Cenric Solutions, IQVIA
• Kristie Moffett, Senior Director, Moffitt Cancer Center

Study start-up delays remain a major barrier to clinical trial efficiency and patient access. The Site-Sponsor Consortium (SSC)—a collaboration among sponsors, CROs, and institutional and commercial sites—was formed to address these persistent challenges. This panel will unveil SSC’s inaugural whitepaper, outlining actionable strategies to streamline and harmonize CDA processes. Panelists will explore ethical and operational imperatives for reform, the role of master and bilateral CDAs, and the collaborative journey to consensus. Attendees will gain practical insights to accelerate start-up timelines and promote transparency, shared responsibility, and industry-wide alignment. Study start-up delays remain a major barrier to clinical trial efficiency and patient access. The Site-Sponsor Consortium (SSC)—a collaboration among sponsors, CROs, and institutional and commercial sites—was formed to address these persistent challenges. This panel will unveil SSC’s inaugural whitepaper, outlining actionable strategies to streamline and harmonize CDA processes. Panelists will explore ethical and operational imperatives for reform, the role of master and bilateral CDAs, and the collaborative journey to consensus. Attendees will gain practical insights to accelerate start-up timelines and promote transparency, shared responsibility, and industry-wide alignment.

Wednesday, February 4 at 9:50 am

Speakers:

• Kate Yawman, Director, Product Management, Advarra
• Nick Spittal, Chief Operations Officer, Velocity Clinical Research

Accelerating study start-up and improving operational outcomes requires sponsors to support sites within their established ways of working. This session explores how connected and easily accessible technology with aligned workflows can reduce inefficiencies, strengthen collaboration, and enhance visibility across study operations. Through real-world examples, we’ll highlight how greater technological harmony between stakeholders contributes to more efficient start-up, stronger engagement, and the realization of connected research.